Document Detail


Early phase combined therapeutic management of acute ischaemic stroke.
MedLine Citation:
PMID:  15883687     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
An adequate treatment of ischaemic stroke in the early phase (28-48 h) is the most important factor for a better outcome. Thrombolysis with rTPA (within 3 h) and oral ASA 300 mg/days are the first therapeutic misures. Continuous monitoring of cardiological and haemodinamic parameters allows early detection of cardiac disturbances. Treatment of hypertension, low haematic oxigenation, hyperglicaemia, seizures and hypertermia is basic to improve outcome. Pharmacological therapy is only one of the components of effective multidisciplinary integrated management of ischaemic stroke; we remind also the precocity of rehabilitation procedures and an accurate psychological assessment.
Authors:
P Bassi; P Lattuada; S Tonietti
Related Documents :
15043617 - Predicting treatment dose for novel therapies using urea standard kt/v.
6631977 - Methodological issues in the study of sex therapy: effective components in the treatmen...
25330347 - Differential effects of exercise on brain opioid receptor binding and activation in rats.
21059667 - The effects of preoperative exercise therapy on postoperative outcome: a systematic rev...
3685117 - Clinical measurements to assess cardiopulmonary function.
3177627 - Heat production of rat anococcygeus muscle during isometric contraction.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology     Volume:  26 Suppl 1     ISSN:  1590-1874     ISO Abbreviation:  Neurol. Sci.     Publication Date:  2005 May 
Date Detail:
Created Date:  2005-05-10     Completed Date:  2005-07-18     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  100959175     Medline TA:  Neurol Sci     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  S29-30     Citation Subset:  IM    
Affiliation:
Neurological Department, San Carlo Borromeo Hospital, Via Pio II 3, I-20153 Milan, Italy. bassi.pietro@sancarlo.mi.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Brain Ischemia / drug therapy*
Emergency Treatment
Fibrinolytic Agents / therapeutic use*
Humans
Rehabilitation
Thrombolytic Therapy / methods*
Time Factors
Tissue Plasminogen Activator / therapeutic use*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Fibrinolytic Agents; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Specific therapies for ischaemic stroke: rTPA and others.
Next Document:  Antibodies associated with paraneoplastic neurological disorders.